Journal: Current Pharmaceutical Design Volume: 12 Issue: 7 Year: 2006 Page: 799-805 Author(s): Shandra S. Wilson, E. D. C.
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 9 Issue: 1 Year: 2009 Page: 29-37 Author(s): Shanhong Ling, Paul A. Komesaroff, Krishnankutty Sudhir
Journal: Current Drug Targets Volume: 14 Issue: 4 Year: 2013 Page: 401-407 Author(s): Lucy J. Schmidt, Donald J. Tindall
Journal: Anti-Cancer Agents in Medicinal Chemistry Volume: 9 Issue: 1 Year: 2009 Page: 1046-1051 Author(s): Nima Sharifi
Ebook: Frontiers in Drug Design and Discovery Volume: 8 Year: 2017 Author(s): Patricia Tai,Evgeny Sadikov,Asim Amjad,Nelson Leong,Arbind Dubey,Wojciech Dolata,Miroslav Jancewicz,Rashmi Koul Doi: 10.2174/9781681083551117080005
Journal: Current Drug Targets Volume: 14 Issue: 4 Year: 2013 Page: 420-440 Author(s): Michael V. Fiandalo, Wenjie Wu, James L. Mohler
Journal: Current Pharmaceutical Design Volume: 10 Issue: 5 Year: 2004 Page: 513-522 Author(s): Jean Closset, Hayet Ammar, Viet-Ha Nguyen, Anne Cornet, Eric Reiter
Ebook: Advances in Genome Science Volume: 1 Year: 2013 Author(s): G.N. Brooke,J. Waxman,C. L. Bevan Doi: 10.2174/9781608051298113010006
Journal: Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Volume: 1 Issue: 1 Year: 2014 Page: 11-19 Author(s): Takashi Kawahara,Hiroshi Miyamoto
Journal: Current Cancer Drug Targets Volume: 15 Issue: 4 Year: 2015 Page: 314-326 Author(s): Yasuhide Kitagawa,Satoru Ueno,Hiroyuki Konaka,Atsushi Mizokami,Shiro Hinotsu,Hideyuki Akaza,Mikio Namiki
Previous Next